1. Department of Cardiology, Referral Center for Cardiac Amyloidosis, GRC Amyloid Research Institute, DHU A-TVB, APHP CHU Henri Mondor and Université Paris Est Créteil, Créteil, France
2. Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
3. Department of Neurosciences and Mental Health, CHULN-Hospital de Santa Maria, CHULN, Hospital de Santa Maria, Lisboa, Portugal
4. Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, CIBERCV, Madrid, Spain
5. Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcon, Spain
6. Division of Medicine, National Amyloidosis Centre, University College London, London, UK
7. Medialis Ltd., Banbury, UK
8. Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, Faculty of Life Science & Medicine, King’s College University, London, UK
9. Akcea Therapeutics UK, Surrey, UK
10. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden
11. Andrade’s Center for Familial Amyloidosis, Porto, Portugal
12. Department of Neurosciences, Hospital de Santo António, Porto, Portugal